Oral administration of ferulic acid in AD mice results in β-carboxy-terminal amyloid precursor protein (APP) cleavage, reduction in Aβ fibril formation, oxidative stress, and neuroinflammation [182]. The gene discussed is APP; the disease is Alzheimer disease.